Abstract
Oxidative stress can be a significant cause of cell death and apoptosis. We performed studies in HepG2 cells to explore whether prior exposure to oxidative stress (“oxidative preconditioning”) and geldanamycin (GA) treatment can protect the cell from damage caused by subsequent oxidative insults. The cells were treated with 10 nM GA for 24 h before oxidative stress. Oxidative preconditioning was achieved by 2 h exposures to H2O2 (50 μM) separated by a 10-h recovery period in normal culture medium. Oxidative stress was induced by exposure to 500 μM H2O2 for 24 h. The effects of GA and oxidative preconditioning were investigated on the formation of Hsp90, vimentin, insoluble vimentin aggregates, and cleavage of vimentin in a cell culture model of oxidative stress. GA treatment leads to enhanced expression of Hsp90 and vimentin and to inhibition of vimentin protein aggregation. Similar results were obtained by oxidative preconditioning. It is confirmed that low concentrations of GA protected HepG2 cells from subsequent oxidative stress by increasing the levels of Hsp90 and by alleviating the extent of cell apoptosis induced by oxidative stress, which is similar to oxidative preconditioning. However, in contrast to preconditioning, GA treatment obviously changed binding activity of Hsp90 to vimentin cleavages. All the above indicated that low concentrations of GA treatment triggered cell protection from oxidative stress. Both the level of Hsp90 and its ability to bind with vimentin were changed by low concentrations of GA and might contribute to oxidative stress protection.
Similar content being viewed by others
Abbreviations
- 17-AAG:
-
17-Allylamino-17-demethoxygeldanamycin
- GA:
-
Geldanamycin
- Hsp90:
-
Heat shock protein 90
- DMSO:
-
Dimethyl sulfoxide
- FITC:
-
Fluorescein isothiocyanate
- GA:
-
Geldanamycin
- H2O2 :
-
Hydrogen peroxide
- Hsp:
-
Heat shock protein
- MTT:
-
3[4,5-dimethylthiazole-2-yl]2,5-diphenyltetrazolium bromide
- PBS:
-
Phosphate-buffered saline
References
Belichenko I, Morishima N, Separovic D (2001) Caspase-resistant vimentin suppresses apoptosis after photodynamic treatment with a silicon phthalocyanine in Jurkat cells. Arch Biochem Biophys 390:57–63. doi:10.1006/abbi.2001.2365
Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296:550–553. doi:10.1126/science.1068999
Byun Y, Chen F, Chang R, Trivedi M, Green KJ, Cryns VL (2001) Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Differ 8:443–450. doi:10.1038/sj.cdd.4400840
Cairns NJ, Lee VMY, Trojanowski JQ (2004) The cytoskeleton in neurodegenerative diseases. J Pathol 204:438–449. doi:10.1002/path.1650
Coulombe PA, Wong P (2004) Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds. Nat Cell Biol 6:699–706. doi:10.1038/ncb0804-699
Diana MT, Guo ZT, Aida H, Jian L (2005) Cellular integrity plus: organelle-related and protein-targeting functions of intermediate filaments. Trends Cell Biol 15:608–617. doi:10.1016/j.tcb.2005.09.004
Dou F, Netzer WJ, Tanemura K, Li F, Hartl FU, Takashima A, Gouras GK, Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498. doi:10.1038/35078107
Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411:494–498. doi:10.1038/35078107
Gao T, Newton AC (2002) The turn motif is a phosphorylation switch that regulates the binding of Hsp90 to protein kinase C. J Biol Chem 277:31585–31592. doi:10.1074/jbc.M204335200
Goldfarb LG, Vicart P, Goebel HH, Dalakas MC (2004) Desmin myopathy. Brain 127:723–734. doi:10.1093/brain/awh033
Gotz J, Ittner LM, Schonrock N (2006) Alzheimer's disease and frontotemporal dementia: prospects of a tailored therapy. Med J Aust 185:381–384
Hong H, Huizhen W, Hong L, Stanley N, Zhiguo W (2001) Oxidative preconditioning and apoptosis in L-cells—roles of protein kinase B and mitogen-activated protein kinases. J Biol Chem 276:26357–26364. doi:10.1074/jbc.M011136200
Ivaska J, Pallari HM, Nevo J, Eriksson JE (2007) Novel functions of vimentin in cell adhesion, migration, and signaling. Exp Cell Res 313:2050–2062. doi:10.1016/j.yexcr.2007.03.040
Jakob U, Buchner J (1994) Assisting spontaneity: the role of Hsp90 and small Hsps as molecular chaperones. Trends Biochem Sci 19:205–211. doi:10.1016/0968-0004(94)90023-X
Jakob U, Lilie H, Meyer I, Buchner J (1995a) Transient interaction of hsp90 with early unfolding intermediates of citrate synthase—implications for heat shock in vivo. J Biol Chem 270:7288–7294. doi:10.1074/jbc.270.13.7288
Jakob U, Meyer I, Bugl H, Andre S, Bardwell JC, Buchner J (1995b) Structural organization of prokaryotic and eukaryotic Hsp90. Influence of divalent cations on structure and function. J Biol Chem 270:14412–14419. doi:10.1074/jbc.270.24.14412
Jiro F, Shuji B, Yu Y, Fei W, Yuji O, Takeo Y, Toshihiko I (2003) High molecular weight vimentin complex is formed after proteolytic digestion of vimentin by caspase-3: detection by sera of patients with interstitial pneumonia. Microbiol Immunol 47(6):447–451
Katschinski DM, Le L, Heinrich D, Wagner KF, Hofer T, Schindler SG, Wenger RH (2002) Heat induction of the unphosphorylated form of hypoxia-inducible factor-1alpha is dependent on heat shock protein-90 activity. J Biol Chem 277:9262–9267. doi:10.1074/jbc.M110377200
Kimmins S, MacRae TH (2000) Maturation of steroid receptors: an example of functional cooperation among molecular chaperones and their associated proteins. Cell Stress Chaperones 5:76–86. doi:10.1379/1466-1268(2000)005<0076:MOSRAE>2.0.CO;2
Kurt Z, Conny S, Andrea F, Elke J, Helmut D (2004) Intermediate filament protein inclusions. Methods Cell Biol 78:205–228. doi:10.1016/S0091-679X(04)78008-5
Lai BT, Chin NW, Stanek AE, Keh W, Lanks KW (1984) Quantitation and intracellular localization of the 85K heat shock protein by using monoclonal and polyclonal antibodies. Mol Cell Biol 4:2802–2810
Lewis J, Devin A, Miller A, Lin Y, Rodriguez Y, Neckers L, Liu ZG (2000) Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation. J Biol Chem 275:10519–10526. doi:10.1074/jbc.275.14.10519
McClellan AJ, Scott MD, Frydman J (2005) Folding and quality control of the VHL tumor suppressor proceed through distinct chaperone pathways. Cell 121:739–748. doi:10.1016/j.cell.2005.03.024
Miyata Y, Yahara I (1992) The 90-kDa heat shock protein, HSP90, binds and protects casein kinase II from self-aggregation and enhances its kinase activity. J Biol Chem 267:7042–7047
Morishima N (1999) Changes in nuclear morphology during apoptosis correlate with vimentin cleavage by different caspases located either upstream or downstream of Bcl-2 action. Genes Cells 4:401–414. doi:10.1046/j.1365-2443.1999.00270.x
Muller K, Dulku S, Hardwick SJ, Skepper JN, Mitchinson MJ (2001) Changes in vimentin in human macrophages during apoptosis induced by oxidized low density lipoprotein. Atherosclerosis 156:133–144. doi:10.1016/S0021-9150(00)00641-9
Nollen EA, Morimoto RI (2002) Chaperoning signaling pathways: molecular chaperones as stress-sensing 'heat shock' proteins. J Cell Sci 115:2809–2816
Nomura M, Nomura N, Newcomb EW, Lukyanov Y, Tamasdan C, Zagzag D (2004) Geldanamycin induces mitotic catastrophe and subsequent apoptosis in human glioma cells. J Cell Physiol 201:374–384. doi:10.1002/jcp.20090
Omary MB, Coulombe PA, McLean WHI (2004) Intermediate filament proteins and their associated diseases. N Engl J Med 351:2087–2100. doi:10.1056/NEJMra040319
Pekny M, Lane EB (2007) Intermediate filaments and stress. Exp Cell Res 313:2244–2254. doi:10.1016/j.yexcr.2007.04.023
Prasad SC, Thraves PJ, Kuettel MR, Srinivasarao GY, Dritschilo A, Soldatenkov VA (1998) Apoptosis-associated proteolysis of vimentin in human prostate epithelial tumor cells. Biochem Biophys Res Commun 249:332–338. doi:10.1006/bbrc.1998.9137
Price JT, Quinn JM, Sims NA, Vieusseux J, Waldeck K, Docherty SE, Myers D, Nakamura A, Waltham MC, Gillespie MT, Thompson EW (2005) The heat shock protein 90 inhibitor, 17-allylamino-17-demethoxygeldanamycin, enhances osteoclast formation and potentiates bone metastasis of a human breast cancer cell line. Cancer Res 65:4929–4938. doi:10.1158/0008-5472.CAN-04-4458
Prodromou C, Roe SM, O’Brien R, Ladbury JE, Piper PW, Pearl LH (1997) Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell 90:65–75. doi:10.1016/S0092-8674(00)80314-1
Richter K, Hendershot LM, Freeman BC (2007) The cellular world according to Hsp90. Nat Struct Mol Biol 2:90–94. doi:10.1038/nsmb0207-90
Salim S, Eikenburg DC (2007) Role of 90-kDa heat shock protein (Hsp 90) and protein degradation in regulating neuronal levels of G protein-coupled receptor kinase 3. J Pharmacol Exp Ther 320:1106–1112. doi:10.1124/jpet.106.114835
Schneider C, Sepp-Lorenzino L, Nimmesgern E, Ouerfelli O, Danishefsky S, Rosen N, Hartl FU (1996) Pharmacologic shifting of a balance between protein refolding and degradation mediated by Hsp90. Proc Natl Acad Sci U S A 93:4536–14541. doi:10.1073/pnas.93.25.14536
Schumacher JA, Crockett DK, Kojo SJ, Megan SL (2007) Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells. Proteomics 7:2603–2616. doi:10.1002/pmic.200700108
Shaknovich R, Shue G, Kohtz DS (1992) Conformational activation of a basic helix-loop-helix protein (MyoD1) by the C-terminal region of murine HSP90 (HSP84). Mol Cell Biol 12:5059–5068
Sittler A, Waelter S, Wedemeyer N, Hasenbank R, Scherzinger E, Eickhoff H, Bates GP, Lehrach H, Wanker EE (1998) SH3GL3 associates with the Huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates. Mol Cell 2:427–436. doi:10.1016/S1097-2765(00)80142-2
Sittler A, Lurz R, Lueder G, Priller J, Lehrach H, Hayer-Hartl MK, Hartl FU, Wanker EE (2001) Geldanamycin activates a heat shock response and inhibits Huntingtin aggregation in a cell culture model of Huntington’s disease. Hum Mol Genet 10(12):1307–1315. doi:10.1093/hmg/10.12.1307
Smith DF, Whitesell L, Nair SC, Chen S, Prapapanich V, Rimerman RA (1995) Progesterone receptor structure and function altered by geldanamycin, an hsp90-binding agent. Mol Cell Biol 15:6804–6812
Soti C, Radics L, Yahara I, Csermely P (1998) Interaction of vanadate oligomers and permolybdate with the 90-kDa heat-shock protein, Hsp90. Eur J Biochem 255:611–617
Stebbins CE, Russo AA, Schneider C, Rosen N, Hartl FU, Pavletich NP (1997) Crystal structure of an Hsp90–geldanamycin complex: targeting of a protein chaperone by an antitumor agent. Cell 89:239–250
Supko JG, Hickman RL, Grever MR, Malspeis L (1995) Preclinical pharmacologic evaluation of geldanamycin as an antitumor agent. Cancer Chemother Pharmacol 36:305–315
van Engeland M, Kuijpers HJ, Ramaekers FC, Reutelingsperger CP, Schutte B (1997) Plasma membrane alterations and cytoskeletal changes in apoptosis. Exp Cell Res 235:421–430
Whitesell L, Mimnaugh EG, De Costa B, Myers CE, Neckers LM (1994) Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation. Proc Natl Acad Sci USA 91:8324–8328
Wiech H, Buchner J, Zimmermann R, Jakob U (1992) Hsp90 chaperones protein folding in vitro. Nature 358:169–170
Young JC, Agashe VR, Siegers K, Hartl FU (2004) Pathways of chaperone mediated protein folding in the cytosol. Mol Cell 5:781–791
Zhang MH, Lee JS, Kim HJ, Jin D, Kim J, Lee KJ, Seo JS (2006) HSP90 protects apoptotic cleavage of vimentin in geldanamycin-induced apoptosis. Mol Cell Biochem 281:111–121
Zou J, Guo Y, Guettouche T, Smith DF, Voellmy R (1998) Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell 94:471–480
Acknowledgments
This work was supported by grants from the National Natural Science Foundation of China (30500580), the National Natural Science Foundation of Guangdong Province (5300465), and the National Basic Research Program of China, No. 2006CB504100.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chen, X., Kang, H. & Zou, F. Low concentration of GA activates a preconditioning response in HepG2 cells during oxidative stress—roles of Hsp90 and vimentin. Cell Stress and Chaperones 14, 381–389 (2009). https://doi.org/10.1007/s12192-008-0092-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12192-008-0092-7